Notably, responder patients exhibited a pronounced increase in activated B cells, as well as naïve and central memory B and T cells, whereas non-responder patients uniquely display the presence of CD4 T regulatory cells (Fig. S2A–D) [17], known to repress tumor-specific CD8 T cells cytotoxicity. This evidence concerns the gene CD4 and neoplasm.